Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Emergency Medicine|April 20, 2005
Managing the difficult airway: a survey of residency directors and a call for changeTimothy J Reeder, Charles K Brown, Donald L Norris
The American Journal of Emergency Medicine|November 24, 2016
Artificial neural networks: Predicting head CT findings in elderly patients presenting with minor head injury after a fallMichael W Dusenberry, Charles K Brown, Kori L Brewer
The American Journal of Emergency Medicine|April 1, 2011
Can clinical prediction rules used in acute pediatric ankle and midfoot injuries be applied to an adult population?Kimberly R Smith, Charles K Brown, Kori L Brewer
Carcinogenesis|August 22, 2006
D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1Sunga Choi, Karen L Lew, Hui Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2007
Masquerader: high mobility group box-1 and cancerJessica E Ellerman, Charles K Brown, Michael de Vera, et al.
Annals of Surgical Oncology|November 27, 2008
A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancerHerbert J Zeh, Charles K Brown, Matthew P Holtzman, et al.
Journal of Cell Science|February 14, 2003
Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cellsNikolai N Khodarev, Jianqing Yu, Edwardine Labay, et al.
FEBS Letters|May 12, 2004
Glioblastoma cells block radiation-induced programmed cell death of endothelial cellsCharles K Brown, Nikolai N Khodarev, Jianqing Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Multicenter, phase II study of axitinib, a selective second-generation inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, in patients with metastatic melanomaJohn Fruehauf, Jose Lutzky, David McDermott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonistsPetar J Popovic, Richard DeMarco, Michael T Lotze, et al.
Pageof 2